• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment.

作者信息

Valke Lars L F G, Beckers Erik A M, Blijlevens Nicole M A, van Heerde Waander L, Schols Saskia E M

机构信息

Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Haemophilia Treatment Centre, Nijmegen, The Netherlands.

出版信息

Haemophilia. 2020 Nov;26(6):e327-e330. doi: 10.1111/hae.14085. Epub 2020 Jun 28.

DOI:10.1111/hae.14085
PMID:32596863
Abstract
摘要

相似文献

1
Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment.艾美赛珠单抗对凝血酶生成的影响：一例艾美赛珠单抗治疗期间突破性出血的病例报告。
Haemophilia. 2020 Nov;26(6):e327-e330. doi: 10.1111/hae.14085. Epub 2020 Jun 28.
2
A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.一种改良的凝血酶生成试验，用于评估在emicizumab（一种针对IXa/X因子的双特异性抗体）存在下的血浆凝血潜力。
Int J Hematol. 2020 Nov;112(5):621-630. doi: 10.1007/s12185-020-02959-x. Epub 2020 Aug 3.
3
Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors.针对两名有抑制剂的严重血友病 A 患儿患者，采用emicizumab 预防措施进行手术。
Pediatr Blood Cancer. 2021 Jul;68(7):e29041. doi: 10.1002/pbc.29041. Epub 2021 Apr 13.
4
Major surgery management in patients with haemophilia A and inhibitors on emicizumab prophylaxis without global coagulation monitoring.在接受emicizumab预防治疗且无全面凝血监测的甲型血友病和抑制剂患者中的大手术管理
Br J Haematol. 2020 May;189(3):e100-e103. doi: 10.1111/bjh.16512. Epub 2020 Feb 22.
5
Emicizumab should be prescribed independent of immune tolerance induction.依库珠单抗的使用不应依赖于免疫耐受诱导。
Blood Adv. 2018 Oct 23;2(20):2783-2786. doi: 10.1182/bloodadvances.2018015859.
6
Antithrombin exhibits anticoagulant effects on the emicizumab-based engineered bispecific antibody (NXT007)-mediated blood coagulation.抗凝血酶对基于emicizumab的工程化双特异性抗体（NXT007）介导的血液凝固具有抗凝作用。
Thromb Res. 2024 May;237:14-17. doi: 10.1016/j.thromres.2024.03.021. Epub 2024 Mar 21.
7
Safety and efficacy of emicizumab and other novel agents in newborns and infants.艾美赛珠单抗及其他新型药物在新生儿和婴儿中的安全性与有效性。
Haemophilia. 2019 Sep;25(5):e334-e335. doi: 10.1111/hae.13822. Epub 2019 Jul 30.
8
A boy with joint pain associated with emicizumab treatment: The importance of plasma level measurement.一名接受emicizumab治疗后出现关节疼痛的男孩：血浆水平测量的重要性。
Haemophilia. 2020 May;26(3):e138-e140. doi: 10.1111/hae.13965. Epub 2020 Apr 16.
9
Initiation of emicizumab prophylaxis in an infant with haemophilia A and subdural haemorrhage.对一名患有甲型血友病和硬膜下出血的婴儿开始使用emicizumab进行预防治疗。
Haemophilia. 2020 Nov;26(6):e353-e355. doi: 10.1111/hae.14133. Epub 2020 Sep 6.
10
Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies.艾美赛珠单抗治疗伴有同种抗体的 3 型血管性血友病患儿的疗效。
Blood Adv. 2019 Sep 24;3(18):2748-2750. doi: 10.1182/bloodadvances.2019000656.

引用本文的文献

1
Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review.用于监测血友病 A 止血治疗的凝血酶生成：叙述性综述。
J Thromb Haemost. 2022 Apr;20(4):794-805. doi: 10.1111/jth.15640. Epub 2022 Jan 28.
2
Clinical use of thrombin generation assays.凝血酶生成试验的临床应用。
J Thromb Haemost. 2021 Dec;19(12):2918-2929. doi: 10.1111/jth.15538. Epub 2021 Oct 8.
3
Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation.甲型血友病中凝血因子 VIII 替代疗法的药效学监测：结合凝血酶和纤溶酶生成情况
J Thromb Haemost. 2020 Dec;18(12):3222-3231. doi: 10.1111/jth.15106. Epub 2020 Oct 21.